A panel at the Financial Times’ 2024 Global Pharma and Biotech Summit in London analyzed what the re-election of Trump could mean to the pharmaceutical industry.
Mike Hollan
Advertisement
Articles by Mike Hollan
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Medical Economics
1
Rapid Nexus wins FDA Clearance for first device targeting root causes of chronic wounds
2
Survey: Rural physician compensation remains out of step with productivity
3
Music and dementia; Scotland tests free Wegovy access; women and long COVID – Morning Medical Update
4
